Alternative Conditioning Regimens Incorporating Bortezomib (Bor) or Carmustine (car) with High-Dose Melphalan (HDM) are Safe and Effective for Multiple Myeloma Patients (pts) Receiving a Second Autologous Stem Cell Transplant (AutoSCT)
2018 ◽
Vol 24
(3)
◽
pp. S134
2016 ◽
Vol 34
(15_suppl)
◽
pp. 8001-8001
◽
2012 ◽
Vol 53
(12)
◽
pp. 2507-2510
◽
2014 ◽
Vol 55
(12)
◽
pp. 2967-2969
◽
2019 ◽
Vol 25
(3)
◽
pp. S281
Keyword(s):
2018 ◽
Vol 24
(3)
◽
pp. S144
Keyword(s):